StockData
NRC Health logo

NRC Health (NRC) stock

NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3080% above fair value
$26.33−0.23 (-0.87%)

Close on Nov 16, 2026Market cap $582.41MP/E –Yield 1.97%

NRC Health r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for NRC Health

NRC Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NRC Health figures

See a number that looks wrong?